The functions of mammalian cellular clock proteins are additionally regulated through posttranslational modifications through various kinases, methylation, polyadenylation, histone modifications, and non-coding RNAs (Mendoza-Viveros et al., 2017
Health status considerations: Generally healthy adults with physician clearance, individuals without contraindications (pregnancy, active malignancy, severe organ disease), those willing to commit to proper administration protocols and monitoring, and patients who understand the research-purposes-only status and informed consent requirements
Heres what we do know from the few human reports available, and why they offer limited reassurance: Phase I trial (unpublished): In 2015, a formal Phase I trial on 42 healthy volunteers was initiated to assess BPC-157s safety and pharmacokinetics
Following these guidelines is crucial, as using an incompatible diluent could cause precipitation of the drug or inactivation of the drugs therapeutic effect
This product is sold exclusively to qualified researchers and scientific professionals
